Karen Thomas

2.8k total citations
26 papers, 951 citations indexed

About

Karen Thomas is a scholar working on Dermatology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Karen Thomas has authored 26 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Rheumatology. Recurrent topics in Karen Thomas's work include Acne and Rosacea Treatments and Effects (6 papers), Spondyloarthritis Studies and Treatments (5 papers) and Dermatology and Skin Diseases (4 papers). Karen Thomas is often cited by papers focused on Acne and Rosacea Treatments and Effects (6 papers), Spondyloarthritis Studies and Treatments (5 papers) and Dermatology and Skin Diseases (4 papers). Karen Thomas collaborates with scholars based in United Kingdom, United States and Netherlands. Karen Thomas's co-authors include Sandra K. Kostyk, Deb Kegelmeyer, Anne Kloos, Kristen A. Sethares, Helen Fox, C Popescu, Klaus F. Rabe, Sarah Garner, E. Anne Eady and William E. Berger and has published in prestigious journals such as Cochrane Database of Systematic Reviews, BMJ and British Journal of Cancer.

In The Last Decade

Karen Thomas

26 papers receiving 905 citations

Peers

Karen Thomas

PHYSI

PRM

DERMA

PTSTR

Gyung‐Jae Oh South Korea

Emel Ceylan Türkiye

B. Filipiak Germany

Vildan Sümbüloğlu Türkiye

Liisa Hiltunen Finland

Yan Lv China

A Venuti Italy

Koji Teruya Japan

Kieran J. Killian Canada

Beatriz Mangueira Saraiva-Romanholo Brazil

Gyung‐Jae Oh South Korea

Karen Thomas

89 ×0.3

PHYSI

105 ×0.4

PRM

22 ×0.1

31 ×0.2

DERMA

24 ×0.2

PTSTR

Citations per year, relative to Karen Thomas Karen Thomas (= 1×) peers Gyung‐Jae Oh

Countries citing papers authored by Karen Thomas

Since Specialization

Citations

This map shows the geographic impact of Karen Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Thomas more than expected).

Fields of papers citing papers by Karen Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Thomas. The network helps show where Karen Thomas may publish in the future.

Co-authorship network of co-authors of Karen Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Thomas. A scholar is included among the top collaborators of Karen Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Thomas. Karen Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santer, Miriam, Beth Stuart, Tracey Sach, et al.. (2024). Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technology Assessment. 28(56). 1–86. 5 indexed citations

Santer, Miriam, Zina Eminton, Beth Stuart, et al.. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 381. e074349–e074349. 25 indexed citations

Sach, Tracey, Zina Eminton, Beth Stuart, et al.. (2023). Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial. BMJ Open. 13(12). e073245–e073245. 3 indexed citations

Stuart, Beth, Ingrid Müller, Alison Layton, et al.. (2021). Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs). BMJ Open. 11(3). e034047–e034047. 8 indexed citations

Horst‐Bruinsma, Irene van der, Frank D. Verbraak, Atul Deodhar, et al.. (2021). Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211003803–1759720X211003803. 18 indexed citations

Thomas, Karen, et al.. (2021). High-intensity interval training and pulmonary hemodynamics in COPD with hypoxemia. European Clinical Respiratory Journal. 8(1). 1984642–1984642. 7 indexed citations

Landewé, Robert, Désirée van der Heijde, Maxime Dougados, et al.. (2020). Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Annals of the Rheumatic Diseases. 79(7). 920–928. 47 indexed citations

Landewé, R., Désirée van der Heijde, Maxime Dougados, et al.. (2020). Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE. Rheumatology and Therapy. 7(3). 581–599. 17 indexed citations

Woods, Mary, et al.. (2020). A Service Development Evaluation of Retrospective Data Exploring Prophylactic Risk-Reducing Advice for Patients with Gynecological Cancers. Journal of Gynecologic Surgery. 36(4). 198–204. 1 indexed citations

10.

Khan, Khurum, L. Rhoda Molife, Karen Thomas, et al.. (2016). Phase I trial outcomes in older patients with advanced solid tumours. British Journal of Cancer. 114(3). 262–268. 14 indexed citations

11.

Konstan, Michael W., Mark Higgins, Gerhild Angyalosi, et al.. (2013). Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial. Current Medical Research and Opinion. 29(8). 947–956. 38 indexed citations

12.

Konstan, Michael W., Mark Higgins, Simon Piggott, et al.. (2012). WS5.6 A challenging double-blind, placebo-controlled study of tobramycin inhalation powder in cystic fibrosis: results of the EDIT trial. Journal of Cystic Fibrosis. 11. S12–S12. 6 indexed citations

13.

Thomas, Karen & Kristen A. Sethares. (2010). Is Guided Imagery Effective in Reducing Pain and Anxiety in the Postoperative Total Joint Arthroplasty Patient?. Orthopaedic Nursing. 29(6). 393–399. 32 indexed citations

14.

Tivarus, Madalina E., et al.. (2008). Dopaminergic Modulation of Semantic Priming in Parkinson Disease. Cognitive and Behavioral Neurology. 21(3). 134–137. 16 indexed citations

15.

Thomas, Karen & Kristen A. Sethares. (2008). An Investigation of the Effects of Preoperative Interdisciplinary Patient Education on Understanding Postoperative Expectations Following a Total Joint Arthroplasty. Orthopaedic Nursing. 27(6). 374–381. 30 indexed citations

16.

Thomas, Karen & Carolyn Watson. (2008). Restless Legs Syndrome in Women: A Review. Journal of Women s Health. 17(5). 859–868. 11 indexed citations

17.

Bousquet, Jean, Klaus F. Rabe, Marc Humbert, et al.. (2007). Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respiratory Medicine. 101(7). 1483–1492. 231 indexed citations

18.

Chipps, Bradley E., Roland Buhl, Kai-Michael Beeh, et al.. (2006). Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion. 22(11). 2201–2208. 38 indexed citations

19.

Cherian, A M, et al.. (1997). EFFECTIVENESS OF P2AM (PAM - PRALIDOXIME) IN THE TREATMENT OF ORGANOPHOSPHORUS POISONING (OPP) A RANDOMIZED, DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL. Journal of the Association of Physicians of India. 45(1). 22–24. 30 indexed citations

20.

Rawson, James R.Y., Karen Thomas, & Michael T. Clegg. (1982). Purification of total cellular DNA from a single plant. Biochemical Genetics. 20(3-4). 209–219. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact